World AIDS 13 Durban 2000

XIII International AIDS Conference, Durban, South Africa, 9-14th July 2000

Mother-to-child transmission, maternal health and women’s access to care

The M in MTCT: questions about HIV-positive mothers

First report of ABT-378/r use in children

Nelfinavir doses should be increased in infants less than 3 months

Metabolic and lipodystropy issues: confusion continues to reign

Switching studies: Can viral load be maintained and metabolic or fat redistribution significantly improved?

Commentary on STI talk, early entry inhibitor research, increase in viral replication seen in isolates in presence of NNRTIs

New developments in affordable antiretroviral therapy: intermittent treatment

Cannabinoids effect on HIV-1 viral load and appetite

IL-2 without HAART may delay need for antiretroviral treatment

New potential dual NNRTI-based combinations

Once-daily protease-based regimens

Mitochondrial DNA (mtDNA) damage in semen as surrogate marker for nucleoside analogue toxicity

Antiretrovirals and fertility – implications for couples looking to conceive

Incidence of adverse events at 4 weeks correlates with adherence and virologic failure at 4 months

Prednisone and nevirapine rash

The prevalence of hypogonadism in HIV positive patients receiving HAART

Human papilloma virus and HIV